Impact of Coronavirus Disease 2019 on Unresectable Hepatocellular Carcinoma Treated with Atezolizumab/Bevacizumab Yun Beom Sang, Chaeryoung Lee, Seul-Gi Kim, Boyoung Lee, Beodeul Kang, Chan Kim, Hong Jae Chon Journal of Clinical Medicine.2024; 13(5): 1335. CrossRef
SARS-CoV-2 Infection and Liver Disease: A Review of Pathogenesis and Outcomes Luke Baldelli, Thomas Marjot, Eleanor Barnes, A. Sidney Barritt, Gwilym J. Webb, Andrew M. Moon Gut and Liver.2023; 17(1): 12. CrossRef
Autoimmune liver disease represented as primary biliary cholangitis after SARS-CoV-2 infection: A need for population-based cohort study Soon Kyu Lee, Jung Hyun Kwon, Nara Yoon, Soon Woo Nam, Pil Soo Sung Clinical and Molecular Hepatology.2022; 28(4): 926. CrossRef
Forms of cholangitis to be considered after SARS-CoV-2 infection Ju-Yeon Cho, Young-Sun Lee, Soon Sun Kim, Do Seon Song, Jeong-Hoon Lee, Ji Hoon Kim Clinical and Molecular Hepatology.2022; 28(4): 929. CrossRef
Management of Patients with Chronic Liver Disease: The Era of the COVID-19 Pandemic Yu Rim Lee The Korean Journal of Gastroenterology.2021; 77(4): 156. CrossRef
Update on liver disease management during the pandemic of coronavirus disease 2019 (COVID-19): 2021 KASL guideline Ju-Yeon Cho, Young-Sun Lee, Soon Sun Kim, Do Seon Song, Jeong-Hoon Lee, Ji Hoon Kim Clinical and Molecular Hepatology.2021; 27(4): 515. CrossRef
Maintaining standard volumes, efficacy and safety, of fecal microbiota transplantation for C. difficile infection during the COVID-19 pandemic: A prospective cohort study Gianluca Ianiro, Stefano Bibbò, Luca Masucci, Gianluca Quaranta, Serena Porcari, Carlo Romano Settanni, Loris Riccardo Lopetuso, Massimo Fantoni, Maurizio Sanguinetti, Antonio Gasbarrini, Giovanni Cammarota Digestive and Liver Disease.2020; 52(12): 1390. CrossRef
Liver transplantation due to hepatocellular adenoma rupture associated with anabolic androgenic steroid abuse Iñigo Jon Garaizabal Azkue, Jon Stampa Ferro, Silvia Torrente Iranzo, Verónica Velasco Benito, Eva García Alberdi, Agustin Castiella Eguzkiza Gastroenterología y Hepatología.2026; 49(5): 502636. CrossRef
Liver transplantation due to hepatocellular adenoma rupture associated with anabolic androgenic steroid abuse Iñigo Jon Garaizabal Azkue, Jon Stampa Ferro, Silvia Torrente Iranzo, Verónica Velasco Benito, Eva García Alberdi, Agustin Castiella Eguzkiza Gastroenterología y Hepatología (English Edition).2026; 49(5): 502636. CrossRef
Hepatocellular Carcinoma Arising in a Huge Hepatocellular Adenoma with Bone Marrow Metaplasia Hyo Jeong Kang, Hui Jeong Jeong, So-Woon Kim, Eunsil Yu, Young-Joo Lee, So Yeon Kim, Jihun Kim Journal of Pathology and Translational Medicine.2018; 52(4): 226. CrossRef
Hepatocellular adenoma: when and how to treat? Update of current evidence Maarten G. Thomeer, Mirelle Broker, Joanne Verheij, Michael Doukas, Turkan Terkivatan, Diederick Bijdevaate, Robert A. De Man, Adriaan Moelker, Jan N. IJzermans Therapeutic Advances in Gastroenterology.2016; 9(6): 898. CrossRef
Evolution of Hepatic Steatosis to Fibrosis and Adenoma Formation in Liver-Specific Growth Hormone Receptor Knockout Mice Yong Fan, Xin Fang, Asako Tajima, Xuehui Geng, Sarangarajan Ranganathan, Henry Dong, Massimo Trucco, Mark A. Sperling Frontiers in Endocrinology.2014;[Epub] CrossRef
Background/Aims The follow-up strategy after hepatectomy for hepatocellular carcinoma (HCC) usually depends on the experience of physician, resulting in frequent imaging studies, which leads to increased cost. Hence, we investigated the role of monitoring alpha-fetoprotein (AFP) levels after hepatectomy in patients with preoperative high AFP. Methods: From January 2000 to December 2004, 66 patients who underwent curative hepatectomy due to HCC with preoperative AFP level >400 ng/ml were reviewed. Changes in AFP level after the operation were investigated. The recurrence was suspected in case of two consecutive increase of AFP over cut-off value. Cut-off value was determined by ROC curve. All patients were divided into 2 groups: patients who met the definition (Group S) and those who didn`t (Group D). Results: AFP level of 20ng/ml was proposed as the cut-off value for diagnosis of recurrence by ROC curve. Thirty two patients who didn`t have the AFP level decreased below 20 ng/ml after the resection had HCC recurred, whereas 16 out of 34 patients who had AFP decreased had tumor recurrence. The AFP level of patients without recurrence was kept below 20 ng/ml during the follow-up. The AFP level of 44 out of 48 recurred patients increased over 20ng/ml upon recurrence. By definition, group D were 5 patients. In 4 patients of group D, the AFP level didn`t increase above 20 ng/ml upon recurrence. These patients had HCC and they recurred 1 year after the surgery. Conclusions: In patients with preoperative AFP level >400 ng/ml, the AFP level tended to increase above 20ng/ml at recurrence mostly within 1 year. Hence, we proposed that these patients could be monitored by only AFP until 1 year after surgery.
Citations
Citations to this article as recorded by
Alpha-fetoprotein level to total tumor volume as a predictor of hepatocellular carcinoma recurrence after resection. A retrospective cohort study Hazem M. Zakaria, Anwar Mohamed, Hazem Omar, Nahla K. Gaballa Annals of Medicine and Surgery.2020; 54: 109. CrossRef
Serum alpha-fetoprotein level per total tumor volume as a predictor of recurrence of hepatocellular carcinoma after resection Yeshika Sharma, Michael J. Weaver, Daniel R. Ludwig, Kathryn Fowler, Neeta Vachharajani, William C. Chapman, Jeffrey S. Crippin Surgery.2018; 163(5): 1002. CrossRef
Localized Uterine Recurrence of Hepatocellular Carcinoma 4 Years after Curative Resection Sang Jin Lee, Jung Woo Shin, Neung Hwa Park, Yang Won Nah, Hang Jo Yoo, Yoong Ki Jung, Hye Jeong Choi Korean Journal of Medicine.2012; 82(5): 603. CrossRef
First
Prev
